Though COVID-19 testing declines continue to negatively affect lab industry profits, the latest figures suggest the worst may be over.
More multiplex COVID-19 combination tests emerge from premarket authorization pipeline.
A recent study revealed burnout rates of 49.9 percent among healthcare professionals during the early stages of the COVID-19 pandemic.
While only time will tell how bad the ultimate damage turns out to be, it appears for now at least that the industry has dodged a bullet.
Cost cutting and restructuring has become the order of the day for many lab companies.